✦ LIBER ✦

Structural analysis of the ErbB-2 receptor using monoclonal antibodies: Implications for receptor signalling

✍ Scribed by Yum L. Yip; Jiri Novotny; Michael Edwards; Robyn L. Ward

Publisher: John Wiley and Sons
Year: 2003
Tongue: French
Weight: 253 KB
Volume: 104
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.10951

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The extracellular part of ErbB‐2 is formed by 4 domains, specifically, L1, L2 that adopt a β‐helical structure and S1, S2 that consist of several cysteine‐rich, EGF‐fold modules. These ectodomains mediate ErbB‐2 dimerisation with itself or with other members of the epidermal growth factor receptor (EGFR) family, events essential to both ErbB‐2 signaling and the development of certain malignancies. The anti‐ErbB‐2 monoclonal antibodies N12, N28 and L87 bind to the polypeptides C531‐A586, T216‐C235 and C220‐C235 respectively. In this study, glycine walking and random mutagenesis were used to further delineate the critical residues involved in antibody binding. A molecular model of ErbB‐2 ectodomains was then constructed based on the recently published coordinates of the EGFR (EGFR) model. This model rationalized successfully many features of our epitope mapping, including their location in modules within the S1 and S2 domains and the importance of Arg545, Gln548 and Leu561 for N12 binding. Further investigation of the functional effects of the anti‐ErbB‐2 monoclonal antibodies demonstrated that N28 strongly stimulated ErbB‐2 phosphorylation and MAPK activation whereas N12 had no effect. As bivalency is required for the action of these antibodies we propose that at least 2 different kinds of ErbB‐2 homodimers can be formed as relative rotational isomers and that the S1 and S2 domains are instrumental in determining the relative orientations of the ErbB‐2 homodimers, such that different signaling effects are induced. © 2003 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Differential localization of ErbB2 in di

Differential localization of ErbB2 in different tissues of the rat female reproductive tract: Implications for the use of specific antibodies for ErbB2 analysis

✍ Nebila Idris; Coralie A. Carothers Carraway; Kermit L. Carraway 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB

## Abstract ErbB2 has been implicated in numerous functions, including normal and aberrant development of a variety of tissues. Although no soluble ligand has been identified for ErbB2, we have recently shown that ASGP‐2, the transmembrane subunit of the cell surface glycoprotein Muc4 (also called

Monoclonal antibody screening of a phage

Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120

✍ Christoph Königs; Merrill J. Rowley; Philip Thompson; Mark A. Myers; Marita Scea 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 2 views

Evaluation of new monoclonal antibodies

Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis

✍ K. Z. Hanley; M. T. Siddiqui; D. Lawson; C. Cohen; A. Nassar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

## Abstract Accurate assessment of estrogen receptor (ER), progesterone receptor (PR), and Her2 status of breast carcinomas is critical for predicting response to systemic therapies. Recently, developed rabbit monoclonal antibodies (RMab) are reported to have higher sensitivity than murine monoclon

Estimation of hormone receptor status an

Estimation of hormone receptor status and HER2 in cytologic cell blocks from breast cancer using the novel rabbit monoclonal antibodies (SP1, SP2, and SP3)

✍ Aziza Nassar; Cynthia Cohen; Momin Siddiqui 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB 👁 2 views

Recombinant antibody toxins specific for

Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo

✍ Marc Azemar; Mathias Schmidt; Friederike Arlt; Pierre Kennel; Burkhard Brandt; A 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 130 KB 👁 2 views

## Overexpression of the ErbB2 and epidermal growth factor receptor (EGFR) tyrosine kinases is frequently observed in squamous cell carcinomas of the head and neck, and has been correlated with shorter overall survival. By immunoblot analysis, we have found EGFR and ErbB2 expression in 6 out of 6 e

Analysis of the genomic structure of the

Analysis of the genomic structure of the human glycine receptor ?2 subunit gene and exclusion of this gene as a candidate for Rett syndrome

✍ Cummings, Chris J.; Dahle, E. Jill Roth; Zoghbi, Huda Y. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB 👁 2 views

The gene that encodes the human ␣2 subunit of the inhibitory glycine receptor (GLRA2) is located on the X chromosome (Xp22.2) in a candidate region for a number of neurological disorders. Recently, an exclusion mapping strategy identified this region to be concordant in familial Rett syndrome (RTT)